Related Experiment Videos

Correction: Interleukin-6 in complications of prematurity: from biomarker to targeted therapy

Shuzhe Xiao^1,2, Qi Zheng^2,3, Lingling Wang³

¹Department of Neonatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Frontiers in Pediatrics

|September 25, 2026

Abstract:

[This corrects the article DOI: 10.3389/fped.2026.1818320.].

Keywords:

IL-6 biomarker immune cell inflammation prematurity complications

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Interleukin-6 in complications of prematurity: from biomarker to targeted therapy.

Frontiers in pediatrics·2026

Neutrophil-to-lymphocyte ratio as a correlative factor of severe SARS-CoV-2 infection in neonates: associations with lymphocyte subsets alterations.

BMC infectious diseases·2026

Mechanism of Houttuynia cordata in treating acute lung injury based on network pharmacology.

Computers in biology and medicine·2025

Early aminophylline is a potential therapy for preventing bronchopulmonary dysplasia in premature infants: a retrospective study.

BMC pediatrics·2025

Analysis and Validation of Autophagy-Related Gene Biomarkers and Immune Cell Infiltration Characteristic in Bronchopulmonary Dysplasia by Integrating Bioinformatics and Machine Learning.

Journal of inflammation research·2025

Predictive modeling of bronchopulmonary dysplasia in premature infants: the impact of new diagnostic standards.

Frontiers in pediatrics·2024

See all related articles